We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Craneware Plc | LSE:CRW | London | Ordinary Share | GB00B2425G68 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-20.00 | -0.90% | 2,210.00 | 2,170.00 | 2,250.00 | 2,210.00 | 2,210.00 | 2,210.00 | 2,134 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Prepackaged Software | 174.02M | 9.23M | 0.2626 | 84.16 | 776.98M |
TIDMCRW
RNS Number : 9714G
Craneware plc
20 March 2020
Craneware plc
("Craneware" or the "Company")
Blocklisting Application
Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that a block listing application has been made to the London Stock Exchange for 350,000 ordinary shares of one pence each ("Ordinary Shares") to be admitted to trading on AIM (the "Admission"). The Ordinary Shares that are being reserved under this block listing application will be issued by the Company, as required, in order to satisfy the exercise of share options and vested awards pursuant to the terms of the following share plans:
Share plan Number of Ordinary Shares The Craneware plc Schedule 4 Company Share Option Plan (2016) 50,000 ------------------- The Craneware plc Unapproved Company Share Option Plan (2016) 200,000 ------------------- The Craneware plc Long Term Incentive Plan (2016) 100,000 ------------------- Total 350,000 -------------------
It is expected that Admission of these Ordinary Shares will become effective on 23 March 2020. When issued, the Ordinary Shares will be credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares.
For further information, please contact:
Craneware plc Peel Hunt Investec Bank Alma (NOMAD & Joint (Joint Broker) (Financial PR) Broker) +44 (0)131 550 +44 (0)20 7418 +44 (0)20 7597 +44 (0)203 405 3100 8900 5970 0205 Keith Neilson, Dan Webster Patrick Robb Caroline Forde CEO Craig Preston, George Sellar Sebastian Lawrence Hilary Buchanan CFO Andrew Clark Henry Reast Helena Bogle
About Craneware
Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions.
Learn more at www.craneware.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ALSPPUWAWUPUUMU
(END) Dow Jones Newswires
March 20, 2020 05:00 ET (09:00 GMT)
1 Year Craneware Chart |
1 Month Craneware Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions